Medpace (MEDP)
(Delayed Data from NSDQ)
$421.31 USD
-2.65 (-0.63%)
Updated Jul 19, 2024 04:00 PM ET
1-Strong Buy of 5 1
C Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
MEDP 421.31 -2.65(-0.63%)
Will MEDP be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for MEDP based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MEDP
Backlog Conversion Likely to Aid Medpace's (MEDP) Q2 Earnings
Top Stocks to Buy for Growth as Earnings Approach
MEDP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Adverum Biotechnologies (ADVM) Stock Outpacing Its Medical Peers This Year?
Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?
SGRY vs. MEDP: Which Stock Is the Better Value Option?
Other News for MEDP
Notable earnings after Monday's close
Medpace Q2 2024 Earnings Preview
Top Stocks To Buy For Growth As Earnings Approach
Medpace Holdings Reaches Analyst Target Price
Peering Into Medpace Hldgs's Recent Short Interest